Tazarotene increases the antipsoriatic effect of dithranol in chronic psoriasis;Tazaroten verstarkt den antipsoriatischen effekt von dithranol bei der chronisch stationaren psoriasis (CSP)

Hautarzt

Volumn 50, Issue 10, 1999, Pages 723-727

  Sander, Patrick ^a   Happe, Marcus ^b   Stücker, Markus ^b   Hermes, Nico ^b   Hoffmann, Klaus ^b   Altmeyer, Peter ^b  

^a ST JOSEF HOSPITAL   (Germany)

^b NONE

Author keywords

Combination therapy; Dithranol; Psoriasis; Tazaroten

Indexed keywords

DITHRANOL; TAZAROTENE; DERMATOLOGICAL AGENT; NICOTINIC ACID DERIVATIVE; RETINOID;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG POTENTIATION; HUMAN; PSORIASIS; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; CHRONIC DISEASE; COMPARATIVE STUDY; DRUG COMBINATION; FEMALE; GEL; MALE; MIDDLE AGED; PROSPECTIVE STUDY;

ANTHRALIN; CHRONIC DISEASE; DERMATOLOGIC AGENTS; DRUG COMBINATIONS; DRUG SYNERGISM; FEMALE; GELS; HUMANS; MALE; MIDDLE AGED; NICOTINIC ACIDS; PROSPECTIVE STUDIES; PSORIASIS; RETINOIDS;

EID: 0032692449     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001050051057     Document Type: Article

References (14)

1. Altmeyer P, Nüchel C (1996) Systemtherapie der Psoriasis. Dtsch Med Wochenschr 121:1605-1607
2. Altmeyer P, Hoffmann K, Stücker M, Goertz S, El Gammal S (1992) General phenomena of ultrasound in dermatology. In: Altmeyer P, Hoffmann K, El Gammal S (eds) Ultrasound in dermatology. Springer Berlin, pp 55-79
3. Altmeyer P, Matthes U, Pawlak F, Hoffmann K, Frosch PJ, Ruppert P, Wassilew SW, Horn T, Kreysel HW, Lutz G et al. (1994) Antipsoriatic effect of fumaric acid derivates. Results of a multicenter double-blind study in 100 patients. J Am Acad Dermatol 30:977-981
4. Bacharach-Buhles M, Röchling A, el Gammal S, Altmeyer P (1996) The effect of fumaric acid esters and dithranol on acanthosis and hyperproliferation in psoriasis vulgaris. Acta Derm Venereol 76:190-193
5. Chandarata RAS (1996) Tazaroten - first of a new generation of receptor - selective retinoids. Br J Dermatol 135:18-25
6. De Luca LM (1991) Retinoids and their receptors in differentiation, embryogenesis and neoplasia. FASEB J 5:2924-2933
7. Gloor M, Graf R, Wirth H (1983) Untersuchungen zur Wirkungsweise einer Psoriasisbehandlung mit Dithranol im Vergleich zu einer Kombinationsbehandlung mit Dithranol und einem Kortikosteroid. Hautarzt 34:500-503
8. Grattan CE, Christopher AP, Robinson M, Cowan MA (1988) Double-blind comparison of a dithranol and steroid mixture with a conventional dithranol regimen for chronic psoriasis. Br J Dermatol 119:623-626
9. Herrlich P, Ponta H (1994) Mutual cross-modulation of steroid/retinoic acid receptor an AP1 transcription factor activities. Trends Endocrinol Metab 5:341-346
10. Hoffmann K, Dirrschka T, Schwarze H, el Gammal S, Matthes U, Hoffmann A, Altmeyer P (1995) 20 MHz sonography, colorimetry and image analysis in the evaluation of psoriasis vulgaris. J Dermatol Science 9:103-110
11. Nagpal S, Athanikar J, Chandraratna RAS (1995) Separation of transactivation and AP1 antagonism functions of retinoic acid receptor α. J Biol Chem 270:923-927
12. Sander P, Stücker M, Hermes N, Hoffmann K, Altmeyer P (1998) Mometason und Calcipotriol optimieren den therapeutischen Initialeeffekt von Dithranol auf die chronisch-stationäre Psoriasis vulgaris. Hautarzt 49:291-294
13. Weinstein GD (1996) Safety, efficacy and duration of therapeutic effect of Tazaroten used in the treatment of plaque psoriasis. Br J Dermatol 135:32-36
14. Yang-Yen H, Zhang X, Graupner G (1991) Antagonismn between retinoic acid receptors and AP1: implications for tumor promotion and inflammation. New Biol 3:1206-1219